Interleukin-6 receptor - TosohAlternative Names: CD 126; Interleukin-6 receptor
Latest Information Update: 16 Aug 2002
At a glance
- Originator Tosoh
- Mechanism of Action Interleukin 6 stimulants; Stem cell stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Stem cell mobilisation
Most Recent Events
- 18 Jun 1998 Preclinical development for Stem cell mobilisation in Japan (Unknown route)